PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-45

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    The only negative about this announcement is the time delay i.e. a one month wait.

    The negatives about the previous announcements were the time delay + uncertainty around if and when the IND would be opened. This uncertainty justified the drop in SP since Paradigms entire existence revolves around iPPS.

    In other words, the current drop in SP represents a significant discount to what will invariable be a massive increase in 30 days time. It is uncovering opportunities like these that make tracking companies such as PAR well worth the time and effort. I'm just hoping the SP falls further so I can grab a bigger discount.

    not advice, DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.